Key Highlights

  • First-half Revenue rose 9.4% reported to $318.2m and 4.7% on an organic constant-currency basis.
  • The adjusted Operating Margin reached 23.0% from 21.6%, meeting the medium-term ambition early.
  • The pharmaceutical Manufacturing disposal completed in June 2026, yielding around $35m of net cash.
  • Net Debt fell to $163.8m, or 1.1 times EBITDA, close to the 1x target.

Elementis plc (LSE:ELM) has spent two years quietly dismantling the conglomerate it used to be. The specialty chemicals group sold its Talc Business in May 2025 and its pharmaceutical manufacturing arm in June 2026, leaving a two-division company built around Personal Care and Coatings additives. Has the market caught up with the change?

The half-year results published on 30 July 2026 offer the first clean look at the slimmed-down group. Organic revenue rose 4.7%, adjusted operating profit climbed 16.4% and the adjusted margin reached 23.0%, the level Elementis had set as a medium-term ambition. With a £25m buyback under way, the issue now is whether the second half can sustain that momentum against a soft North American coatings market.

Half-year results: margins hit the 23% target early

The interim results for the six months to 30 June 2026, released on 30 July 2026, showed revenue from continuing operations of $318.2m, up 9.4% reported from $290.8m and 4.7% on an organic constant-currency basis. Adjusted operating profit rose to $73.2m from $62.9m, lifting the margin to 23.0% from 21.6%.

Personal Care revenue rose 10.0% reported to $109.2m, or 2.9% organically, at a 38.1% adjusted margin, with mid-teens growth in Japan and Korea offsetting muted Americas demand. Coatings revenue grew 9.1% reported to $209.0m, or 5.6% organically, at a 20.7% margin, as Asia and Europe outweighed North American weakness.

Chief executive Luc van Ravenstein said: "Revenue in the first half is up 5% organic constant currency, profits are up 16% and margins are also improving while net debt is close to our 1x target." The Interim Dividend rose 15.4% to 1.5 cents, payable on 25 September 2026.

The results also confirmed the 2 June 2026 sale of the pharmaceutical manufacturing business to Associated British Foods for an Enterprise value of €34.3m, yielding net cash of around $35m and a $13.0m book gain. Those proceeds fund the £25m buyback launched on 3 June 2026. Elementis said the exit lifts the group adjusted margin by 56 basis points.

A pure-play additives business after the disposals

Elementis makes performance additives, small-volume ingredients that change how a finished product flows, feels or performs. Its distinctive asset is hectorite, a rare clay mined in California that underpins rheology modifiers used across both divisions. Personal Care supplies ingredients for colour cosmetics, skin care, hair care and antiperspirants. Coatings serves architectural, automotive, industrial, marine and specialty paint formulators, plus a smaller energy business.

In the 2025 financial year Personal Care generated 37.6% of revenue but 50.8% of adjusted operating profit, while Coatings delivered 62.4% of revenue and 49.2% of profit. Alchemy Ingredients, a natural rheology modifier specialist bought in November 2025 for a $22m enterprise value, is already delivering double-digit revenue growth in skincare and suncare.

Full-year 2025 performance: profit up despite flat sales

Preliminary results for the year to 31 December 2025, published on 5 March 2026, showed revenue of $597.5m, down 1.0% reported and 1.9% at constant currency, as a 4.3% constant-currency decline in Coatings offset 2.4% growth in Personal Care. Adjusted operating profit still rose to $126.7m from $119.2m, with the margin up 150 basis points to 21.2%, helped by $24m of cost savings.

Adjusted profit before tax was $107.5m, up 11.2%, and adjusted Diluted Earnings per Share rose 14.2% to 13.7 cents, although the statutory result was distorted by a $110.5m loss on the Talc disposal. Free Cash Flow was $41.0m against $51.0m in 2024, and net debt ended the year at $185.4m, or 1.3x EBITDA, after a £40.0m buyback and dividends returned about $79m to shareholders. The full-year dividend rose 7.5% to 4.3 cents.

By 30 June 2026 net debt had fallen to $163.8m, or 1.1x EBITDA, with cash of $86.2m. First-half free cash flow was a modest $13.3m, held back by higher inventories from stronger sales, raw-material pre-buying and Middle East-related inflation. Elementis said it remains confident of full-year performance in line with market expectations, citing consensus adjusted operating profit of $132.5m for 2026.

What could move the shares next

The immediate test is the third-quarter trading update. Investors will look for evidence that Coatings can keep growing in Asia and Europe while North America stays weak, and that Personal Care's Americas business has recovered.

The buyback is a steady support. In the week to 21 August 2026 Elementis bought 700,000 shares at between 176.8p and 182.2p, leaving 567.2m shares with voting rights and implying a Market Value of around £1bn. Completion of the £25m programme, and any further returns once Leverage settles at 1x, will be watched.

Longer term, the Elevate Elementis strategy targets mid-single-digit revenue growth through the cycle, a 23%-plus adjusted margin, cash conversion above 90% and return on Capital employed above 30% excluding goodwill. Delivery hinges on lifting innovation revenue towards 20% of sales from 16.4%, taking hectorite into agrochemicals, fire retardants and cleaning products, and expanding in Southeast Asia and India, with selective bolt-on deals.

Risks investors should watch

Coatings remains exposed to a cyclical, construction-linked market that has been soft for several years, and North America has yet to turn; further deterioration there would weigh on a division that still generates more than 60% of revenue.

Elementis reports in US dollars and has significant American manufacturing, so Tariff policy and currency swings cut both ways; the $1.2m tariff refund booked in the first half, following a February 2026 US Supreme Court ruling, shows how unpredictable trade policy remains. Management has also flagged the Middle East crisis as a risk to demand, input costs and Supply chains, although direct revenue exposure is below 2%.

Working capital absorbed cash in the first half and free cash flow of $13.3m was low relative to profit, so inventory needs to unwind to meet the cash-conversion target. And with the margin goal already reached, further progress depends on revenue growth, which has been modest, rather than on more cost cutting.

Outlook

The half-year numbers suggest the reshaping has produced a higher-quality, higher-margin business than the one investors saw two years ago. Whether the market rewards that depends on Elementis (LSE:ELM) meeting consensus of $132.5m adjusted operating profit for 2026 and on what the third-quarter update says about demand.

Points to monitor are North American coatings volumes, the pace of the buyback, second-half cash generation and whether Asia can keep delivering. Elementis has reached its margin target early; the next chapter is proving it can grow.